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Abstract Many epidemiological studies showed associ-
ations of low birth weight with cardiovascular disease, type
2 diabetes and obesity. The associations seem to be con-
sistent and stronger among subjects with a postnatal catch
up growth. It has been suggested that developmental
changes in response to adverse fetal exposures might lead
to changes in the fetal anatomy and physiology. These
adaptations may be beneﬁcial for short term, but may lead
to common diseases in adulthood. Maternal smoking dur-
ing pregnancy is one of the most important adverse fetal
exposures in Western countries, and is known to be asso-
ciated with a 150–200 g lower birth weight. An accumu-
lating body of evidence suggests that maternal smoking
during pregnancy might be involved in pathways leading to
both low birth weight and common diseases, including
cardiovascular disease, type 2 diabetes and obesity, in
adulthood. In this review, we discuss epidemiological
studies focused on the associations of maternal smoking
with fetal growth and development and cardiovascular and
metabolic disease in later life. We also discuss potential
biological mechanisms, and challenges for future epide-
miological studies.
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Introduction
Cardiovascular disease, type 2 diabetes and obesity are
common diseases with major impact on morbidity and
mortality in adulthood [1–4]. Multiple epidemiological
studies, of which many have been published in the Euro-
pean Journal of Epidemiology, identiﬁed various risk fac-
tors in childhood and adulthood for these diseases [5–35].
The developmental origins of health and disease hypoth-
esis postulates that adverse fetal exposures lead to perma-
nent fetal adaptations in structure, physiology and
metabolism [36]. These adaptations might be beneﬁcial for
short term fetal survival, but may lead to fetal growth
retardation and cardiovascular and metabolic diseases in
adulthood [36]. Strong support for this hypothesis comes
from many epidemiological studies showing that low birth
weight is associated with increased risks of cardiovascular
disease, type 2 diabetes and obesity [37–41]. However, the
effect estimates for the associations between low birth
weight and diseases in later life seem to be small and
underlying causal mechanisms are unknown [38–41]. Since
the same birth weight might be the result of various fetal
exposures and growth patterns, low birth weight is unlikely
to be the causal factor per se leading to of cardiovascular
disease, diabetes and obesity. Maternal smoking is one of
the most important modiﬁable adverse risk factors for low
birth weight in Western countries, and might be involved in
the underlying mechanisms [29].
In this review, we discuss epidemiological studies
focused on the associations of maternal smoking during
pregnancy with fetal growth and cardiovascular and
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smoke exposure in the mechanisms underlying the asso-
ciations between low birth weight and diseases in later life,
and challenges for future epidemiological studies.
Maternal smoking during pregnancy and fetal
development
Although the negative effects of smoking during pregnancy
on fetal growth are well known, the prevalence of smoking
during pregnancy is still high. In western countries, up to
25% of all pregnant women smoke during pregnancy [41].
Maternal smoking is one of the most important modiﬁable
risk factors for low birth weight in Western countries [29].
The effects of maternal smoking during pregnancy on fetal
outcomes seem to be dose and trimester dependent
[42, 43]. It has been suggested that smoking during ﬁrst
trimester only and quitting thereafter, does not lead to
increased risks of neonatal complications [42, 43]. Mater-
nal smoking may primarily affect fetal peripheral tissue
and skeletal growth. Fetal femur length is already affected
from second trimester onwards [44]. Recently, it has been
shown that ﬁrst trimester fetal growth, as measured by
crown-rump length, is also affected by maternal smoking
[45].
The biological mechanisms by which maternal smoking
during pregnancy inﬂuences fetal growth are not fully
known. Various substances related to maternal smoking
might be involved. Nicotine is an important teratogen and
it induces vasoconstriction which leads to reduced pla-
cental blood ﬂow and oxygen deprivation in the fetus [46].
Fetal vasoconstriction and impaired blood ﬂow may lead to
suboptimal hemodynamic stimulus for placental and fetal
vascular development [47, 48]. Other toxins from maternal
smoking also lead to reduced placental and fetal perfusion
[48–51]. Some studies suggest that nicotine directly inﬂu-
ences cell proliferation and differentiation, hereby affect-
ing neural cell survival and the development of fetal
neurotransmitter systems [49]. Another teratogenic element
in smoking is carbon monoxide, which is rapidly absorbed
in the blood where it binds to haemoglobin and forms
carboxyhaemoglobin which results in hypoxia, and might
be teratogenic and fetotoxic [50]. Animal studies show a
direct negative effect of prenatal carbon monoxide expo-
sure on cardiac maturation [51]. Cadmium is also a toxic
constituent of tobacco smoke. It is known to accumulate in
the placenta. In human trophoblast cells, cadmium inhibits
activity of 11-b-hydroxysteroid dehydrogenase type 2
(11-b-HSD2). Reduced placental 11-b-HSD2 enzyme activ-
ity, needed for the metabolism of cortisol into the inactive
cortisone, may lead to fetal growth restriction [52]. Other
constituents, including additives present in cigarettes, have
shown to be teratogenic or fetotoxic in animals, but their
effect on the human fetus are largely unknown [53].
Although, the association of maternal smoking with low
birth weight is well known, not much is known about the
effects of maternal smoking on fetal organ function and
development [54–61]. Among the offspring of mothers
who continued smoking during pregnancy, the estimated
fetal weight and birth weight were most severely affected
in those with the highest umbilical artery resistance, sug-
gesting that the effect of maternal smoking during preg-
nancy on fetal growth is at least partly mediated by
placental and fetal circulatory adaptations. Third trimester
umbilical artery resistance indices seem also to be associ-
ated with a reduced aortic root diameter in postnatal life
[62]. These ﬁndings may suggest that increased arterial
resistance in response to fetal smoke exposure affects the
left atrium and aortic root development in postnatal life.
The persistence of the increased arterial resistance during
life may predispose a person to the development of critical
hypertension, left ventricular hypertrophy and cardiovas-
cular disease in adulthood [62]. It has also been suggested
that continued smoking during pregnancy affects fetal
kidney development. The effect size and direction depends
on the number of cigarettes smoked. Smoking less than ﬁve
cigarettes per day was associated with larger fetal com-
bined kidney volume, whereas smoking more cigarettes
leads to smaller fetal kidneys [63]. Thus far, epidemio-
logical studies on the associations of maternal smoking
during pregnancy on other fetal cardiac structures and
metabolic proﬁles are lacking.
Maternal smoking and risk factors for cardiovascular
disease and type 2 diabetes in adulthood
Accumulating body of evidence suggests that maternal
smoking during pregnancy also affects the development of
risks factors for cardiovascular disease and type 2 diabetes
in the offspring. Fetal smoke exposure might lead to pro-
gramming of the cardiovascular system [64]. Several
studies have shown that blood pressure is higher among
children of mothers who smoked during pregnancy [65–
69]. However this association was not always clearly
present [70]. It has been suggested that quitting smoking
during early pregnancy prevent the adverse effects on the
offspring blood pressure [66, 71]. Brion et al. assessed the
associations of both maternal and paternal smoking during
pregnancy on blood pressure in the offspring, and observed
similar effect estimates for both maternal and paternal
smoking. If maternal smoking would program the fetal
cardiovascular system due to direct fetal exposure, stronger
effect estimates would be observed for maternal than for
paternal smoking [69]. Their ﬁnding may therefore suggest
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ronmental mechanisms might be involved in the underlying
mechanisms. Thus far, the study with the longest follow up
has been performed in the United Kingdom. Power et al.
demonstrated that maternal smoking during pregnancy was
associated with higher blood pressure in adults aged
45 years [72].
The increase in blood pressure in childhood may pre-
dispose to development of hypertension and cardiovascular
disease in later life. The association between smoking
during pregnancy and elevated childhood blood pressure
indicates that there might be an increase in peripheral
vascular resistance which leads to decreased blood ﬂow
and oxygen delivery. One study with a small number of
children showed that on the ﬁrst postnatal day there is
indeed less tissue oxygenation in children exposed to
smoking in utero [73].
A long term follow-up study showed that fetal smoke
exposure is associated with an increased rise in total cho-
lesterol levels and appears to lead to an adverse lipoprotein
proﬁle. It has to be noticed that this effect was restricted to
the offspring in the highest body mass index tertile [74].
Fetal smoke exposure may also negatively affect the vas-
cular wall and eventually lead to atherosclerosis [75].
Recent studies in animals and young children support the
hypothesis that maternal smoking during pregnancy nega-
tively affects the lipid proﬁle in childhood [76, 77].
Several studies have been published showing associa-
tions of maternal smoking with obesity in later life. It has
been suggested that maternal smoking during pregnancy is
associated with an increase in body weight from childhood
until adulthood [72, 78–82]. Fetal tobacco exposure is
associated with an increase in body mass index and waist
circumference in adulthood [72]. A systematic review
showed that smoking exposure in utero appears to increase
the rate of overweight already in childhood [78]. A study
on body fat composition in infancy showed no association
between maternal smoking and subcutaneous fat mass in
early childhood [83]. Recently, it has been shown that
children of mothers who smoke only in ﬁrst trimester of
pregnancy, do not have a higher risk of overweight, sug-
gesting that the second half of pregnancy is the critical time
period [84]. In the same study, it has been shown that
paternal smoking was not associated with obesity in the
offspring, suggesting direct intra uterine effects.
No extensive research has been performed on the asso-
ciations of maternal smoking during pregnancy with type 2
diabetes or impaired glucose tolerance in the offspring.
However, recent animal studies suggest that fetal smoking
exposure might cause metabolic changes which lead to
type 2 diabetes [85, 86].
In summary, an accumulating body of evidence suggest
that fetal smoke exposure is associated with risk factors for
cardiovascular disease, type 2 diabetes and obesity. Thus
far, results seem to be inconsistent and not much is known
about the mechanisms underlying these associations.
Hypothesis
Based on the above mentioned ﬁndings, we hypothesise
that fetal smoke exposure might be involved in the mech-
anisms underlying the associations between low birth
weight and cardiovascular disease, obesity and type 2
diabetes (Fig. 1).
Perspectives for future research
Current studies showing associations of maternal smoking
during pregnancy with risk factors for cardiovascular dis-
ease, type 2 diabetes and obesity do still have some major
limitations. As in any observational study, residual con-
founding due to unmeasured or insufﬁciently measured
confounders might be an issue. Besides fetal smoking
exposure, there are several related maternal factors of
inﬂuence on pregnancy outcomes [87–92]. Recently, it was
concluded from meta-analyses and a systematic review that
heavy alcohol consumption during pregnancy increases the
risks of low birth weight, preterm birth and small for
gestational age [92]. It has been suggested that ﬁsh con-
sumption and high caffeine intake during pregnancy does
not signiﬁcantly affect birth weight [93, 94]. However, job
circumstances during pregnancy might cause adverse
effects, and exposure to pesticides is associated with
decreased birth weight [95].
Study designs accounting for potential confounders on
the effect of maternal smoking on postnatal outcome are
needed. For example, studies which look at effects of
paternal smoking among non-smoking mothers and studies
which look at the effects of siblings exposed and non-
exposed to maternal smoking [69, 84] When these possible
confounders will be taken into account, it might be able to
identify the speciﬁc intra uterine or general environmental
effects of fetal smoke exposure [96–109].
Furthermore, future studies might use more detailed
measurements [110–113]. Maternal smoking during preg-
nancy is most frequently measured by questionnaires. More
objective measurements, such as cotinin levels might be
useful. Also, for the outcomes, more detailed measurements
of cardiovascular properties, such as pulse wave velocity,
endothelial function, lipid spectrums and glucose responses
might lead to better insight in the underlying vascular and
metabolic mechanisms. Measurements of body composition
by dual X energy absorptiometry, or Magnetic Resonance
Imaging (MRI) will provide information about body growth
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maternal smoking during pregnancy. MRI studies also
enable studies on liver steathosis, visceral fat and thoracal
fat [114–116].
The effects of maternal smoking on the fetus might
differ between subjects. Genetic susceptibility might be
important. Fetal exposures might cause epigenetic altera-
tions. This is one mechanism by which adverse fetal
environment might increase the risk of disease in later life.
Smoking during pregnancy causes changes in fetal DNA
methylation. A study of DNA methylation in buccal cells
showed signiﬁcant alterations in children with in utero
smoke exposure [117]. Recently, another study conﬁrmed
the association between prenatal smoke exposure and
methylation alterations. It was concluded that there is an
inverse dose response relationship between DNA methyl-
ation in cord serum and serum cotinine levels [118].
In conclusion, fetal smoke exposure might be involved
in the mechanisms underlying the associations between
low birth weight and cardiovascular disease, obesity and
type 2 diabetes. Well designed epidemiological studies,
which take account for potential confounders are needed,
and focus on speciﬁc underlying mechanisms are needed.
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